Skip to main content
Log in

Malignant B-cells have receptors for and respond to interleukin-2

  • Growth Factors and Hormones
  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

Interleukin-2 (IL-2) for a long time has been considered as a T-cell specific growth factor which acts through distinct surface receptors present on activated, but not on resting, T-lymphocytes. Recently it has been shown that activated murine and human B-cells also express IL-2 receptors and respond to IL-2 with an increase of DNA synthesis. Some human B-cell malignancies have been reported to react with anti-IL-2 receptor antibodies, but no response to IL-2 has been documented in these cases. Here, in five of 11 B-cell leukemia/lymphoma cases, we identified cells which not only express the IL-2 receptor, but also respond to IL-2 stimulation, as shown by a marked increase of3H-thymidine incorporation and by differentiation of lymphoma cells. The IL-2-induced3H-thymidine uptake was completely blocked by a monoclonal antibody to IL-2 receptor, which indicates that IL-2 acted directly through functional IL-2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Larsson E L, Iscove N, Coutinho A: Two distinct factors are required for induction of T cell growth.Nature 283, 664 (1980).

    Article  PubMed  CAS  Google Scholar 

  2. Cantrell D A, Smith K A: Transient expression of IL-2 receptors. Consequences for T cell growth.J Exp Med 158, 1895 (1983).

    Article  PubMed  CAS  Google Scholar 

  3. Gordon J, Åman P, Rosen A, Ernberg I, Henriksson B E, Klein G: Capacity of B-lymphocytic lines of diverse tumor origin to produce and respond to B-cell growth factors: a progression model for B-cell lymphomagenesis.Int J Cancer 35, 251 (1985).

    Article  PubMed  CAS  Google Scholar 

  4. Howard M, Farrar J, Hilfiker M, Jonson B, Takatsu K, Hamaoka T, Paul W E: Identification of a T cell-derived B cell growth factor distinct from Interleukin-2.J Exp Med 155, 914 (1982).

    Article  PubMed  CAS  Google Scholar 

  5. Takatsu K, Tanaka K, Tominaga A, Kumahara Y, Hamaoka T: Antigen induced T cell-replacing factor (TRF). III. Establishment of a T cell hybrid clone continuously producing TRF and functional analysis of released TRF.J Immun 125, 2646 (1980).

    PubMed  CAS  Google Scholar 

  6. Sideras P, Bergstedt-Linqvist S, MacDonald H R, Severinson E: Secretion of IgG1 induction factor by T cell clones and hybridomas.Eur J Immun 15, 586 (1985).

    Article  CAS  Google Scholar 

  7. Vitetta E S, Ohara J, Myers C D, Layton J E, Krammer P H, Paul W E: Serological, biochemical and functional identity of B-cell stimulatory factor I and B-cell differentiation factor for IgG1.J Exp Med 162, 1726 (1985).

    Article  PubMed  CAS  Google Scholar 

  8. Lowenthal J W, Zubler R H, Nabholz M, MacDonald R H: Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes.Nature 315, 669 (1985).

    Article  PubMed  CAS  Google Scholar 

  9. Mingari M C, Gerosa F, Carra G, Accolla R S, Moretta A, Zubler R H, Waldmann T A, Moretta L: Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells.Nature 312, 641 (1984).

    Article  PubMed  CAS  Google Scholar 

  10. Tsudo M, Uchiyama T, Uchino H: Expression of Tac antigen on activated normal B cells.J Exp Med 160, 612 (1984).

    Article  PubMed  CAS  Google Scholar 

  11. Muraguchi M, Kehrl J H, Longo D L, Volkman D J, Smith K A, Fauci A S: Interleukin-2 receptors on human B cells. Implication for the role of Interleukin-2 in human B cell function.J Exp Med 161, 181 (1985).

    Article  PubMed  CAS  Google Scholar 

  12. Walman T A, Goldman C K, Robb J R, Depper J M, Leonard W J, Sharrow J O, Bongiovanni K F, Korsmeyer J J, Greene W C: Expression of Interleukin-2 receptors on activated human B cells.J Exp Med 160, 1450 (1984).

    Article  Google Scholar 

  13. Boyd A W, Fisher D C, Fox D A, Sclossman S F, Nadler L M: Structural and functional characterization of IL-2 receptors on activated human B cells.J Immun 134, 2387 (1985).

    PubMed  CAS  Google Scholar 

  14. Uchiyama T, Broder S, Waldmann T: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac+ cells.J Immun 126, 1393 (1981).

    PubMed  CAS  Google Scholar 

  15. Tomita S, Ambrus J L, Volkman D J, Longo D L, Mitsuya H, Reitz M S, Fauci A S: Human T-cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin-2 by differentiation in the absence of enhanced proliferation.J Exp Med 162, 393 (1985).

    Article  PubMed  CAS  Google Scholar 

  16. Kormeyer S J, Greene W C, Cossman J, Hsu M, Jensen J P, Neckers L M, Marscall S L, Bakhshi A, Depper J M, Leonard W J, Jaffe E S, Waldman T A: Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.Proc Natl Acad Sci USA 80, 4522 (1983).

    Article  Google Scholar 

  17. Touw I, Löwenberg B: Interleukin-2 stimulates chronic lymphocytic leukemia colony formationin vitro.Blood 66, 237 (1985).

    PubMed  CAS  Google Scholar 

  18. Robb R J, Munk A, Smith K A: T cell growth factor receptors: quantitation, specificity and biological relevance.J Exp Med 154, 1455 (1981).

    Article  PubMed  CAS  Google Scholar 

  19. Greene W C, Robb R J, Svetlik P B, Rusk C M, Depper J M, Leonard W J: Stable expression of cDNA encoding the human Interleukin-2 receptor in eukaryotic cells.J Exp Med 162, 363 (1985).

    Article  PubMed  CAS  Google Scholar 

  20. Ralph P, Jeong G, Welte K, Mertelsmann R, Rabin H, Henderson L E, Souiza L M, Boone T C, Robb J R: Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL-2.J Immun 133, 2442 (1984).

    PubMed  CAS  Google Scholar 

  21. Lennert K: Malignant lymphomas other than Hodgkin's disease. InHandbuch der Speziellen Pathologischen Anatomie und Histologie, Band 1, Teil 3B, Berlin, Springer (1978).

    Google Scholar 

  22. Braylan P C, Burke J S: Hairy cell leukemia.Ann Rev Med 30, 17 (1979).

    Article  PubMed  CAS  Google Scholar 

  23. Carbone P, Kaplan H, Muschoff K, Smithers D, Tubiana M: Report of the committee on Hodgkin's disease staging classification.Cancer Res 31, 1860 (1971).

    PubMed  CAS  Google Scholar 

  24. Moretta L, Webb S R, Grossi C E, Lydyard P M, Cooper M D: Functional analysis of two human T cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.J Exp Med 146, 184 (1977).

    Article  PubMed  CAS  Google Scholar 

  25. Porwit, A, Ksiazek T, Biberfeld P: Leu 7+ (HNK1+) cells. I. Selective compartmentalization of Leu 7+ cells with different immunophenotypes in lymphatic tissues and blood.Scand J Immun 18, 485 (1983).

    Article  Google Scholar 

  26. Robb R J, Greene W C, Rusk C M: Low and high affinity cellular receptors for interleukin-2. Implications for the level of Tac antigen.J Exp Med 160, 1126 (1984).

    Article  PubMed  CAS  Google Scholar 

  27. Granelli-Piperno A, Andrus L, Steinman R M: Lymphokine and nonlymphokine mRNA levels in stimulated human T cells: kinetics, mitogen requirements and effect of cyclosporin A.J Exp Med 163, 922 (1986).

    Article  PubMed  CAS  Google Scholar 

  28. Smith K A, Cantrell D A: Interleukin-2 regulates its own receptors.Proc Natl Acad Sci USA 82, 864 (1985).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panayotides, P., Lenkei, R., Porwit, A. et al. Malignant B-cells have receptors for and respond to interleukin-2. Med. Oncol. & Tumor Pharmacother. 3, 255–263 (1986). https://doi.org/10.1007/BF02935002

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02935002

Key words

Navigation